Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION (BSX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Insider Trading Activity Boston Scientific Co. (NYSE:BSX) – SVP Sold 16,286 shares of Stock

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/24/2018 | 12:17pm CET

Insider Trading Activity For Boston Scientific Co. (NYSE:BSX)

David A Pierce , SVP of Boston Scientific Co. (NYSE:BSX) reportedly Sold 16,286 shares of the company’s stock at an average price of 27 for a total transaction amount of $439,722.00 SEC Form

Insider Trading History For Boston Scientific Co. (NYSE:BSX)

  • On 8/6/2012 Ernest Mario, Director, bought 32,000 with an average share price of $5.29 per share and the total transaction amounting to $169,280.00.
  • On 11/9/2012 Nj Nicholas Jr, Director, bought 25,000 with an average share price of $5.17 per share and the total transaction amounting to $129,250.00.
  • On 11/13/2012 Nj Nicholas Jr, Director, bought 20,000 with an average share price of $5.28 per share and the total transaction amounting to $105,600.00.
  • On 5/6/2013 Ernest Mario, Director, bought 30,000 with an average share price of $7.76 per share and the total transaction amounting to $232,800.00.
  • On 5/29/2013 Nelda J Connors, Director, sold 24,116 with an average share price of $9.17 per share and the total transaction amounting to $221,143.72.
  • On 5/30/2013 Wendy Carruthers, SVP, sold 25,001 with an average share price of $9.16 per share and the total transaction amounting to $229,009.16.
  • On 5/31/2013 Jeffrey B Mirviss, SVP, sold 10,941 with an average share price of $9.37 per share and the total transaction amounting to $102,517.17.
  • Analyst Ratings History For Boston Scientific Co. (NYSE:BSX)

    • On 3/12/2016 Deutsche Bank Reiterated Rating Hold
    • On 3/17/2016 Nomura Initiated Coverage of rating Buy with a price target of $22.00
    • On 3/18/2016 Longbow Research Initiated Coverage of rating Buy
    • On 3/25/2016 Bank of America Reiterated Rating Buy with a price target of $23.00
    • On 3/27/2016 Morgan Stanley Reiterated Rating Overweight with a price target of $22.00
    • On 7/28/2016 Benchmark Boost Price Target of rating Buy with a price target of $25.00 to $31.00
    • On 7/29/2016 Wedbush Boost Price Target of rating Neutral with a price target of $23.00 to $25.00

    Recent Trading Activity for Boston Scientific Co. (NYSE:BSX)
    Shares of Boston Scientific Co. closed the previous trading session at with shares trading hands.

    The post Insider Trading Activity Boston Scientific Co. (NYSE:BSX) – SVP Sold 16,286 shares of Stock appeared first on Market Exclusive.

    © Market Exclusive 2018, source Market Exclusive

    share with twitter share with LinkedIn share with facebook
    share via e-mail
    0
    Latest news on BOSTON SCIENTIFIC CORPORAT
    02/24INSIDER TRADING ACTIVITY BOSTON SCIE : BSX) – SVP Sold 16,286 shares of St..
    AQ
    02/23BOSTON SCIENTIFIC CORP : Other Events, Financial Statements and Exhibits (form 8..
    AQ
    02/22BOSTON SCIENTIFIC : Prices $1.0 Billion of Senior Notes
    PR
    02/20BOSTON SCIENTIFIC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
    AQ
    02/15BOSTON SCIENTIFIC : New Head and Neck Cancer Study Findings Have Been Reported f..
    AQ
    02/08BOSTON SCIENTIFIC : An Application for the Trademark "SAVION FLX" Has Been Filed..
    AQ
    02/08BOSTON SCIENTIFIC : An Application for the Trademark "ELUVIA" Has Been Filed by ..
    AQ
    02/01BOSTON SCIENTIFIC : meets earnings expectations, sees stronger 2018 sales
    AQ
    02/01BOSTON SCIENTIFIC : Announces Investment and Acquisition Option Agreement with M..
    AQ
    02/01BOSTON SCIENTIFIC : An Application for the Trademark "TACTRA" Has Been Filed by ..
    AQ
    More news
    News from SeekingAlpha
    02/21Tracking David Tepper's Appaloosa Management Portfolio - Q4 2017 Update 
    02/08Hancock Jaffe Updates IPO Terms 
    02/06Motus GI Files $25 Million IPO Terms 
    02/02Boston Scientific Corporation 2017 Q4 - Results - Earnings Call Slides 
    02/02Boston Scientific's (BSX) CEO Michael Mahoney on Q4 2017 Results - Earnings C.. 
    Financials ($)
    Sales 2018 9 738 M
    EBIT 2018 2 420 M
    Net income 2018 1 444 M
    Debt 2018 3 841 M
    Yield 2018 -
    P/E ratio 2018 25,49
    P/E ratio 2019 22,70
    EV / Sales 2018 4,13x
    EV / Sales 2019 3,77x
    Capitalization 36 362 M
    Chart BOSTON SCIENTIFIC CORPORAT
    Duration : Period :
    Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
    Technical analysis trends BOSTON SCIENTIFIC CORPORAT
    Short TermMid-TermLong Term
    TrendsNeutralNeutralNeutral
    Income Statement Evolution
    Consensus
    Sell
    Buy
    Mean consensus OUTPERFORM
    Number of Analysts 25
    Average target price 31,6 $
    Spread / Average Target 19%
    EPS Revisions
    Managers
    NameTitle
    Michael F. Mahoney Chairman, President & Chief Executive Officer
    John Bradley Sorenson Senior Vice President-Manufacturing & Supply Chain
    Edward Mackey Executive Vice President-Operations
    Daniel J. Brennan Chief Financial Officer & Executive Vice President
    Ian Meredith Global Chief Medical Officer & Executive VP
    Sector and Competitors
    1st jan.Capitalization (M$)
    BOSTON SCIENTIFIC CORPORATION6.82%36 362
    THERMO FISHER SCIENTIFIC10.14%84 125
    DANAHER4.89%67 717
    INTUITIVE SURGICAL17.15%46 779
    ROYAL PHILIPS-0.13%36 282
    ILLUMINA3.78%33 503